Prognostic value of metabolic tumor volume measured by 18F-fluorodeoxyglucose positron emission tomography in patients with esophageal carcinoma. - Wikidata - wikimedia - TriplyDB

Prognostic value of metabolic tumor volume measured by 18F-fluorodeoxyglucose positron emission tomography in patients with esophageal carcinoma.

Prognostic value of metabolic tumor volume measured by 18F-fluorodeoxyglucose positron emission tomography in patients with esophageal carcinoma.

http://www.wikidata.org/entity/Q43261940

about

Prognostic significance of volume-based PET parameters in cancer patients.Introduction to the analysis of PET data in oncology.Prognostic value of baseline FDG uptake on PET-CT in esophageal carcinoma Pretreatment F-18 FDG PET/CT Parameters to Evaluate Progression-Free Survival in Gastric Cancer.Recent Trends in PET Image Interpretations Using Volumetric and Texture-based Quantification Methods in Nuclear Oncology.Prognostic Significance of Volume-based Metabolic Parameters by (18)F-FDG PET/CT in Gallbladder Carcinoma.Metabolic Tumor Volume Measured by F-18 FDG PET/CT can Further Stratify the Prognosis of Patients with Stage IV Non-Small Cell Lung Cancer.Prognostic Value of Volume-Based Metabolic Parameters Measured by (18)F-FDG PET/CT of Pancreatic Neuroendocrine Tumors.Prognostic value of volumetric metabolic parameters measured by [18F]fluorodeoxyglucose-positron emission tomography/computed tomography in patients with small cell lung cancer Metabolic tumor volume is an independent prognostic factor in patients treated definitively for non-small-cell lung cancer FDG-PET Response Prediction in Pediatric Hodgkin's Lymphoma: Impact of Metabolically Defined Tumor Volumes and Individualized SUV Measurements on the Positive Predictive Value.FDG-PET parameters as prognostic factor in esophageal cancer patients: a review.Prognostic value of volume-based positron emission tomography/computed tomography in patients with nasopharyngeal carcinoma treated with concurrent chemoradiotherapy.Prognostic value of metabolic tumor volume and velocity in predicting head-and-neck cancer outcomes.Baseline ¹⁸F-FDG PET image-derived parameters for therapy response prediction in oesophageal cancer Value of sequential 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) in prediction of the overall survival of esophageal cancer patients treated with chemoradiotherapy.Predictive value of initial FDG-PET features for treatment response and survival in esophageal cancer patients treated with chemo-radiation therapy using a random forest classifier.Impact of partial-volume effect correction on the predictive and prognostic value of baseline 18F-FDG PET images in esophageal cancer.Prognostic value of volume-based (18)F-fluorodeoxyglucose PET/CT parameters in patients with clinically node-negative oral tongue squamous cell carcinoma.Prognostic significance of PET assessment of metabolic response to therapy in oesophageal squamous cell carcinoma Total Lesion Glycolysis Using ¹⁸F-FDG PET/CT as a Prognostic Factor for Locally Advanced Esophageal Cancer.Utility of 3'-[(18)F]fluoro-3'-deoxythymidine as a PET tracer to monitor response to gene therapy in a xenograft model of head and neck carcinoma.Prognostic Value of the Sum of Metabolic Tumor Volume of Primary Tumor and Lymph Nodes Using 18F-FDG PET/CT in Patients With Cervical Cancer.Response evaluation after neoadjuvant chemoradiation by positron emission tomography-computed tomography for esophageal squamous cell carcinoma.Prognostic Value of Metabolic and Volumetric Parameters of Preoperative FDG-PET/CT in Patients With Resectable Pancreatic Cancer.The 100 most cited articles investigating the radiological staging of oesophageal and junctional cancer: a bibliometric analysis.Glyceraldehyde-3-phosphate dehydrogenase gene over expression correlates with poor prognosis in non small cell lung cancer patients Prediction of outcome with FDG-PET in definitive chemoradiotherapy for esophageal cancer.Determination of regional lymph node status using (18)F-FDG PET/CT parameters in oesophageal cancer patients: comparison of SUV, volumetric parameters and intratumoral heterogeneity.Incorporating prognostic imaging biomarkers into clinical practice.Prognostic factors in patients after definitive chemoradiation using involved-field radiotherapy for esophageal cancer in a phase II study.Effect of different segmentation algorithms on metabolic tumor volume measured on 18F-FDG PET/CT of cervical primary squamous cell carcinoma PET/CT planning during chemoradiotherapy for esophageal cancer.Recommendations for measurement of tumour vascularity with positron emission tomography in early phase clinical trials.Feasibility of perfusion CT technique integrated into conventional 18FDG/PET-CT studies in lung cancer patients: clinical staging and functional information in a single study.The value of ¹⁸F-FDG PET/CT in the management of malignant peripheral nerve sheath tumors.Prognostic value of metabolic tumor volume as measured by fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in nasopharyngeal carcinoma.Prognostic Value of Metabolic Tumor Volume Measured by 18F-FDG PET/CT in Esophageal Cancer Patients.State-of-the-art molecular imaging in esophageal cancer management: implications for diagnosis, prognosis, and treatment.Metabolic response evaluated by 18F-FDG PET/CT as a potential screening tool in identifying a subgroup of patients with advanced non-small cell lung cancer for immediate maintenance therapy after first-line chemotherapy.

P2860

Q27687836-6BF1F8E8-72C3-45E2-AF95-108D7D200CF2 Q30594766-133B8427-7C04-4040-ABAC-F6265BB99CB1 Q33612675-763CAB9C-D2AB-4E39-8190-7EB45050566D Q33669818-80A5B139-2818-4FD4-A1A8-4FD51DDB7114 Q33669828-C603D421-6B25-4E99-8010-C71C39951F32 Q33704511-9187534C-E438-4387-9FAC-0199BF04B5E8 Q33704656-D848775F-E5F7-4954-B483-6524C15369F1 Q34090931-D15636E5-2692-46AC-AA43-2DC9748801AA Q34419020-4AC00625-4190-4723-A0BC-033CFC19CFAA Q34977651-CDEA52AD-764D-44A3-9B88-E58E57E6C081 Q35237507-E8A797E7-3C35-4ADA-9772-76C381B58946 Q35332601-2EAEE5F6-DC92-4D90-BCD5-5F3AC27EF587 Q35672382-E63472E9-D9BF-485D-9696-5A0A5406EE19 Q35916248-472E764C-B9D7-40D9-A3B5-595FBF2BF61A Q36032993-0ADAD19D-80D6-429F-8D73-DF81147C8C98 Q36046360-8CE435BC-BEE8-4664-9CAD-F91C14AFC8C5 Q36304217-78DFFE50-F5AF-456A-AF26-D0FE7CD158F6 Q36335078-0B63A44C-12E2-4B92-B80C-6161FB63DEA0 Q36357282-DF3EB348-3A69-43AE-ADAF-71F78D9A193A Q36432120-702EEF3E-EECB-4895-A3B6-8E5A22BA96E7 Q36461563-3195470D-2EA7-4C94-B426-CB930EE12DC4 Q36533822-B80611BC-BD2C-4EB4-A77A-2AB0E866E03C Q36664103-7077B563-1B4A-4FD5-9E1C-B51C8F1E8084 Q36775121-1F6F05C5-46EC-4A89-B298-341D3B30FA69 Q36993625-A1859BA2-C8F7-4E40-AAD3-5843FACB581A Q37116282-92839829-9D3B-479F-9DCF-5200C06028B7 Q37153528-55EA6307-F85B-45C8-9B36-CFF81F3E0D23 Q37154079-E6F87ADC-5E6C-46BD-A50D-B45614A4CFA7 Q37175679-FD686D17-C6D0-407E-A9B3-7DBC918C0B79 Q37193816-A5314373-03A3-4DFB-898C-3934B8C1A779 Q37456566-6336718C-94E8-44B7-BE13-C6674F67E9C7 Q37653213-D3E44757-C491-49DF-A86D-F4D963BEEC86 Q37687303-AF381AA8-2D13-4248-8811-318836314108 Q38000044-DF0A9C78-B5D1-4780-A0E5-92660598BA1A Q38059165-FAC7FADC-13B0-4FBA-A997-0155D3C1E0CD Q38202025-6E5136EF-94A5-41B9-8550-BEB4B27CB9A3 Q38249891-521A8A46-A62D-4278-B14F-BBAFC20AF486 Q38327284-667ED2AA-BD5B-49A9-8CFB-86A600C352B6 Q38340518-BC76F85E-2387-4B2C-A3D0-82351CF1417A Q38451242-CE6571E1-1295-4E2E-8D9E-F7F69BC9257A

P2860

Prognostic value of metabolic tumor volume measured by 18F-fluorodeoxyglucose positron emission tomography in patients with esophageal carcinoma.

http://www.wikidata.org/entity/Q43261940

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

Prognostic value of metabolic ...... nts with esophageal carcinoma.

@en

Prognostic value of metabolic ...... nts with esophageal carcinoma.

@nl

type

label

Prognostic value of metabolic ...... nts with esophageal carcinoma.

@en

Prognostic value of metabolic ...... nts with esophageal carcinoma.

@nl

prefLabel

Prognostic value of metabolic ...... nts with esophageal carcinoma.

@en

Prognostic value of metabolic ...... nts with esophageal carcinoma.

@nl

P1433

Q43261940-48AA3956-4042-4C17-A61C-5D49F737EB01

P1476

Q43261940-9C4CFC3D-3D91-4A4E-9DB4-AC180DE7398B

P2093

Q43261940-26C7BD33-DA80-4810-875E-7DF5DD0750ED

Q43261940-87A5B668-0B94-4852-A1B0-1F151399EE0C

Q43261940-8F54C708-2219-4458-8D79-E9464279F388

Q43261940-B0C09405-AB34-407D-AEFC-0E7D5B3D6FB2

Q43261940-CBE83690-9756-4969-9C17-42EF72F450C1

Q43261940-E20457ED-5555-4C68-A920-274B12EC8E37

Q43261940-ED2137F0-C6D2-47D0-A7B6-09D7AE2E5C38

Q43261940-FBD34341-E932-496C-A21C-494116B18DEE

P2860

Q43261940-0DB749F0-E198-408E-99C4-09F74D0C10E3

Q43261940-3AEA0899-A99D-4E93-9304-E92C2C310BFE

Q43261940-55A7542B-C39C-4366-8EB7-634F45A1C2D3

Q43261940-5F95DF2C-FFC0-44FA-A5E3-84BB67142EE4

Q43261940-F66B8B84-C7E2-401F-ABE6-E5DF3759F9F4

P2888

Q43261940-933F2AC1-13BB-4E56-811B-0A988C1B4CCC

P304

Q43261940-7C509F09-2AE1-41D9-AFA9-4A6980B983C4

P31

Q43261940-A8458051-29B1-4241-8322-2FA76A4B5FB1

P356

Q43261940-C5C5C999-3C1B-461F-ABDE-1E02327FE8B0

P433

Q43261940-2EFAA487-3E49-4510-90F6-660AB923DD74

P478

Q43261940-8745B431-D862-439C-B4A3-EA0C21C80194

P50

Q43261940-12B945C6-D9C9-43B0-8162-0CBFD00784CE

P577

Q43261940-DCF10F31-CA01-452C-ADEE-FC1CE586B67D

P6179

Q43261940-60D2B148-036A-428C-8F1B-D7974F62F942

P698

Q43261940-2D8A8700-BCA3-423F-98DB-8A686F01E707

P356

S10434-009-0719-7

P1433

Annals of Surgical Oncology

P1476

Prognostic value of metabolic ...... nts with esophageal carcinoma.

@en

P2093

Byung-Tae Kim

http://www.w3.org/2001/XMLSchema#string

Ji Young Lee

http://www.w3.org/2001/XMLSchema#string

Joon Young Choi

http://www.w3.org/2001/XMLSchema#string

Kwhanmien Kim

http://www.w3.org/2001/XMLSchema#string

Kyung-Han Lee

http://www.w3.org/2001/XMLSchema#string

Seung Hyup Hyun

http://www.w3.org/2001/XMLSchema#string

Young Mog Shim

http://www.w3.org/2001/XMLSchema#string

Young Seok Cho

http://www.w3.org/2001/XMLSchema#string

P2860

Increasing tumor volume is predictive of poor overall and progression-free survival: secondary analysis of the Radiation Therapy Oncology Group 93-11 phase I-II radiation dose-escalation study in patients with inoperable non-small-cell lung cancer.

Measurement of tumor volume by PET to evaluate prognosis in patients with advanced cervical cancer treated by radiation therapy.

Using 18F-fluorodeoxyglucose positron emission tomography to estimate the length of gross tumor in patients with squamous cell carcinoma of the esophagus.

Prognostic value of the standardized uptake value in esophageal cancer.

Metabolic tumor burden predicts for disease progression and death in lung cancer.

P2888

s10434-009-0719-7

P304

115-122

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1245/S10434-009-0719-7

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-10-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1022874094

http://www.w3.org/2001/XMLSchema#string

P698

19826877

http://www.w3.org/2001/XMLSchema#string